From December 31, 2023 to March 30, 2024, the company has repurchased 1,428,242 shares, representing 0.61% for $102.19 million. With this, the company has completed the repurchase of 10,419,336 shares, representing 4.28% for $753.72 million under the buyback announced on September 23, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
74.12 USD | +0.87% | -0.12% | +3.74% |
Jul. 02 | Evercore ISI Adjusts Price Target on Hologic to $76 From $78, Maintains In-line Rating | MT |
Jun. 27 | Stephens Initiates Coverage on Hologic With Overweight Rating, $87 Price Target | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.74% | 17.15B | |
+1.75% | 204B | |
+3.42% | 178B | |
+31.54% | 154B | |
+32.16% | 112B | |
+1.71% | 64.32B | |
+21.08% | 54.88B | |
-1.61% | 47.24B | |
-9.11% | 36.8B | |
-0.34% | 35.26B |
- Stock Market
- Equities
- HOLX Stock
- News Hologic, Inc.
- Tranche Update on Hologic, Inc.'s Equity Buyback Plan announced on September 23, 2022.